PRESENTATIONS

1 – Lim E, Vaillant F, Forrest N, Gyorki D, kConFab, Visvader JE and Lindeman GJ. Characterisation of the human breast mammary and cancer stem cell. Oral presentation at Melbourne Health Research week. Melbourne 2008. (Best oral presentation)
2 – Lim E, Vaillant F, Forrest N, Pal B, Gyorki D, Partanen A, Thorne H, kConFab, Visvader JE and Lindeman GJ. Investigation of stem and progenitor subpopulations in human breast tissue from BRCA1 and BRCA2 carriers. Oral presentation at Clinical Oncological Society of Australia, Sydney 2008. (Best oral presentation)
3 – Lim E, Vaillant F, Wu D, Forrest N, Pal B, Gyorki D, kConFab, Smyth GK, Visvader JE and Lindeman GJ. Investigation of stem and progenitor subpopulations in human breast tissue from BRCA1 and BRCA2 carriers. Oral presentation at the American Society of Clinical Oncology Annual Meeting, Orlando, USA. 2009.
4 – Lim E, Wu D, Pal B, Bouras T, Asselin-Labat ML, Vaillant F, Yagita H, Lindeman GJ, Smyth GK, Visvader JE. Transcriptome analyses of mouse and human mammary cell subpopulations reveals multiple conserved genes and pathways. Poster presentation at the San Antonio Breast Cancer Symposium 2010.
5 – Lim E, He HH, Chi D, Garber JE, Richardson A, Brown M. ER signaling in primary luminal cells from wild type, BRCA1mut, BRCA2mut and ER+ breast cancer. Oral presentation at Dana-Farber/Harvard Cancer Center Women’s Cancer Program ASM. Boston 2012.
6 – Lim E, He HH, Chi D, Garber JE, Richardson A, Brown M. Estrogen receptor signaling in normal, BRCA1 and BRCA2 mutation associated, and ER-positive breast cancer mammary cells. Poster presentation at the American Society of Clinical Oncology Annual Meeting, Chicago, USA. 2012.
7 – Lim E, He HH, Chi D, Yeung TY, Schnitt S, Garber JE, Richardson A, Brown M. Differences in estrogen receptor signaling in non-malignant primary ER-positive breast epithelial cells and breast cancer. Poster Discussion at the San Antonio Breast Cancer Symposium, USA. 2012.
8 – Chi D, He HH, Yeung TY, Jeselsohn R, Schnitt S, Garber JE, Richardson A, Lim E, Brown M. Differential estrogen receptor signaling in normal mammary epithelial cells, primary breast cancers and metastases. Oral Presentation at the American Association of Cancer Research Annual Meeting, DC, USA. 2013.
9 – Lim E, Cao SA, Brown M, Bailey S. Modeling chemoendocrine therapy for ER+/p53wt luminal breast cancer. Poster Presentation at the San Antonio Breast Cancer Conference USA, 2014.
10 – Lim E. Preclinical insights into steroid receptor signaling in breast cancer. Oral Presentation at ANZ Breast Cancer Trialist Group Annual Scientific Meeting, Wellington, NZ 2014.
11 – Lim E. Patient derived breast cancer xenograft models for cancer research. Oral Presentation at Oz Metastases Research Society Symposium, Melbourne, 2014
12 – Lim E. Modeling therapeutic resistance in vivo. Oral Presentation at Gordon Conference on Hormone Receptors in Cancer, Maine, USA. 2015.
13 – Lim E. New applications for Cyclin Dependent Kinase Inhibitors in Triple Negative Breast Cancer. Oral Presentation at Singapore Breast Cancer Symposium, Cancer Research Institute, National University of Singapore. 2015.
14 – Lim E. Steroid Receptor Cross Talk in Breast Cancer. Oral Presentation at the Global Breast Cancer Conference, Jeju, S. Korea 2016.
15 – Lim E. Pathological Complete Response as a surrogate endpoint for survival. Oral presentation at the Controversies in Breast Cancer Meeting. Melbourne. 2016.
16 – Lim E. Extending CDK inhibitors beyond ER+ Breast Cancer. Oral presentation at the HOTT meeting. Sydney. 2016.
17 – Lim E. Role of extended hormonal therapy and Role of HER2-directed therapies in small tumours. Oral presentation at the Controversies in Breast Cancer Meeting, Barcelona, Spain 2016.
18 – Lim E. Translating Biological Insights in ER+ Breast Cancer into Clinical Trials. Oral presentation at the translating molecular insights into clinical practice in breast and prostate cancer Meeting. Cambridge, UK. 2016.
19 – Lim E. Modeling resistance to endocrine therapies. Oral presentation at the Clinical Oncological Society of Australia Meeting. Gold Coast. 2016.
20. Lim E. Translating Biological Insights in ER+ Breast Cancer into Clinical Trials. Oral presentation at the Leura 8 Breast Cancer Conference. NSW. 2016.